(Q53243276)

12 May 2018

title

Preventing schizophrenia and Alzheimer disease: comparative ethics. (English)

1 reference

12 May 2018

1 reference

1 reference

S G Post

1

1 reference

12 May 2018

language of work or name

English

0 references

publication date

1 August 2001

1 reference

12 May 2018

published in

Schizophrenia Research

1 reference

12 May 2018

volume

51

1 reference

12 May 2018

issue

1

1 reference

12 May 2018

page(s)

103-108

1 reference

12 May 2018

Commentary: A Patient's Perspective on Predictive Testing for Alzheimer Disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900246-8

7 January 2021

Cellular and molecular neuropathology of the olfactory epithelium and central olfactory pathways in Alzheimer's disease and schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900246-8

7 January 2021

Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900246-8

7 January 2021

Comparison of a clock drawing test in elderly schizophrenia and Alzheimer's disease patients: a preliminary study.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900246-8

7 January 2021

No increased incidence of Alzheimer's disease in elderly schizophrenics.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900246-8

7 January 2021

A test for the insurance industry.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900246-8

7 January 2021

The clinical introduction of genetic testing for Alzheimer disease. An ethical perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900246-8

7 January 2021

Physicians and patient spirituality: professional boundaries, competency, and ethics

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900246-8

7 January 2021

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900246-8

7 January 2021

No association of apolipoprotein epsilon 4 allele with schizophrenia even in cognitively impaired patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900246-8

7 January 2021

10.1016/S0920-9964(01)00246-8

Identifiers

DOI

1 reference

12 May 2018

PubMed ID

11479072

1 reference

12 May 2018